Home >
FEATURED BLOGS
Mar 30, 2017
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of...
Mar 24, 2017
When everyone around you is telling you that you are overworked and on the verge of burnout, it's time to listen, reflect, and take action for your own well-being.
Mar 23, 2017
We may never be able to completely eliminate anxiety and stress before and after scans, yet we can definitely make a difference by confronting scanxiety upfront.
Mar 20, 2017
When the basics of cancer control are not in place, should we discuss targeted agents and immunotherapy in resource-constrained settings?
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Mar 13, 2017
A supportive network of women colleagues and friends helps Dr. Uma Borate feel more empowered in her oncology career and in her life.
Mar 07, 2017
Bad news is something that we in health care are practised in telling, but I for one have never gotten used to it.
Mar 03, 2017
Whether it's your first or twenty-first time attending the ASCO Annual Meeting, you'll find that connections can happen anywhere, not just during sessions or designated networking events.

Latest Comments & Discussions


ASCO University
Mar 29, 2017
Thank you to Drs. Halmos and Dacic for leading the discussion of this case and also to all of those who contributed to the conversation!...

Sanja Dacic
Mar 29, 2017
 Faculty Summary 1.    MET exon 14 alterations are mutually exclusive with other lung cancer driver mutations such as...

Balazs Halmos, MD
Mar 29, 2017
Faculty Summary 1.    Molecularly definable MET alterations are emerging as a clearly actionable subset of NSCLCs. 2....

Apurva C. Mehta, MD
Mar 28, 2017
You have hit the hammer dot on the nail Prof Gajra!

Sanja Dacic
Mar 24, 2017
Course Faculty Response For METexon 14 alterations testing see case 1. De novo MET amplification occurs in 1-5% of lung...

Pages

Most Read

ASCO and the Conquer Cancer Foundation of ASCO (CCF) proudly announce the winners of ASCO’s Special Awards, the Society’s highest honors, and the CCF Women Who Conquer Cancer Mentorship Award. The recipients of these awards include researchers, patient advocates, and global oncology leaders who...
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
A supportive network of women colleagues and friends helps Dr. Uma Borate feel more empowered in her oncology career and in her life.
Read more to answer the following questions: 1. Who should get routine molecular testing at the time of diagnosis of NSCLC and what genes should be included in the molecular panel? 2. What is the proper timing of testing and sequencing of available therapies? 3. What treatment options are available...
Bad news is something that we in health care are practised in telling, but I for one have never gotten used to it.

Tweets from ASCO

Tweets from Oncology Community